HERTFORDSHIRE, England and PITTSBURGH, May 26, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL), a leading global pharmaceutical company, today announced that Mylan CEO Heather Bresch, will be presenting at the Bernstein Strategic Decisions Conference, Friday, May 29, 2015 at 9 a.m. ET.
Interested parties can access a live webcast of the presentation via the investor relations section of Mylan's website at http://mylan.com/investors. An archived version will also be available following the live presentation and can be accessed at the same location for a limited time.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. Our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com
SOURCE Mylan N.V.